| Revenue growth | 16% YoY GWP growth in FY26. |
|---|---|
| Margins | Combined Ratio improved from 101.1% to 98.8% YoY. |
| Demand visibility | Strong retail health momentum; 93% fresh NOPs are new to insurance. |
| Management confidence | High, citing 'Digital First' strategy and proprietary network strength. |
Growth
FY26 GWP grew 16% to ₹20,369 Cr. Normalised PAT surged 45% YoY to ₹1,222 Cr. Retail fresh GWP rose 37% YoY.
Outlook
Focus on 'Digital First' with 96% premium collection. Expanding Home Health Care to 300+ cities. Sustaining solvency ratio at 2.05x.
Risks
Marked-to-Market investment losses of ₹127 Cr in FY26. Q4 FY26 reported a net loss of ₹55 Cr due to investment volatility.
Earnings Call filed with NSE, NSE: STARHEALTH. Summary written with AI assistance from the document.
Star Health and Allied Insurance Company Ltd: key numbers
- Share price
- ₹557.80
- Market cap
- ₹32,781 Cr
- Revenue (annual)
- ₹17,825 Cr
- Net profit (annual)
- ₹557.0 Cr
- P/E (TTM)
- 31.1×Sector 20.8×
- Promoter holding
- 58.00%-0.01% QoQ
- FII holding
- 15.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Health and Allied Insurance Company Ltd
All →Star Health and Allied Insurance Company Capital Structure Change
Star Health received IRDAI approval for HDFC Mutual Fund schemes to acquire equity up to 9.99% of paid-up capital, up from 4.49%. The approval extends the fund's existing stake and does not involve a stated rupee amount.
Star Health and Allied Insurance Company Results Update
Star Health reported Normalised PAT of ₹390 Crores in Q2 FY27, up 70% YoY. H1 FY27 PAT stood at ₹815 Crores, up 57% YoY.
Star Health and Allied Insurance Company Earnings Call Transcript: Key Takeaways
Star Health reported a significant structural turnaround with underwriting profitability for the fifth consecutive quarter.
- Call
- Guides 20% growth
Star Health and Allied Insurance Company Other Announcement
Star Health filed a NIL Reg 54 security cover certificate for unsecured NCDs. No secured debt is covered, so this is routine compliance.
Star Health and Allied Insurance Company Investor Presentation: Key Takeaways
H1 FY27 PAT ₹815 Cr (+57%); CISR improved to 97.9% from 100.3%; underwriting result ₹210 Cr vs loss ₹24 Cr. Retail fresh GWP +36%, driven by agency and D2C. Reported profit includes ₹229 Cr MTM gain.
Star Health and Allied Insurance Company Promoter Reclassification
Star Health's board approved reclassifying Sthitaprajna Advisors LLP from promoter group to public shareholder category. The move is subject to requisite regulatory approvals.